You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 122 No. 2, February 2004 TABLE OF CONTENTS
  Archives
  •  Online Features
  Clinicopathologic Reports, Case Reports, and Small Case Series
 This Article
 •Full text
 •PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on ISI (2)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Topic Collections
 •Ocular/ Adnexal Tumors
 •Alert me on articles by topic

Long-term Survival in a Patient With Uveal Melanoma and Liver Metastasis

Arch Ophthalmol. 2004;122:285-287.

Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

Uveal melanoma1 is the most common primary ocular malignancy in whites and represents 70% of all primary ocular malignancies. In patients with metastatic uveal melanoma, the prognosis for those with initial metastasis to the liver is particularly poor. The median survival of patients who first develop liver metastasis from uveal melanoma is 5 to 7 months, as compared with 18 months for other initial sites of metastasis.2-4 This poor prognosis continues despite treatment modalities such as chemoembolization.5-6 We report a case of uveal melanoma with initial metastasis to the liver in a patient who survived for more than 5 years after diagnosis of liver metastasis.

Report of a Case.

Possible uveal melanoma in the left eye was diagnosed in a 74-year-old white woman with a history of hypertension. The melanoma was discovered after she sought evaluation for decreased visual acuity in that eye. The patient was seen at the Wilmer Eye Institute, Baltimore, Md, . . . [Full Text of this Article]


Comment.
Elia J. Duh, MD; Andrew P. Schachat, MD
Baltimore, Md

Daniel M. Albert, MD; Sarit M. Patel, MD
Madison, Wis

Corresponding author: Elia J. Duh, MD, 600 N Wolfe St, Jefferson 3-109, Baltimore, MD 21287 (e-mail: eduh@jhmi.edu).



THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Hepatic Resection for Metastatic Melanoma: Distinct Patterns of Recurrence and Prognosis for Ocular Versus Cutaneous Disease
Pawlik et al.
Ann. Surg. Oncol. 2006;13:712-720.
ABSTRACT | FULL TEXT  

Development of Metastatic Disease After Enrollment in the COMS Trials for Treatment of Choroidal Melanoma: Collaborative Ocular Melanoma Study Group Report No. 26
Collaborative Ocular Melanoma Study Group*
Arch Ophthalmol 2005;123:1639-1643.
ABSTRACT | FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2004 American Medical Association. All Rights Reserved.